Ionis Pharmaceuticals Inc (NASDAQ:IONS)

43.80
Delayed Data
As of May 22
 +0.57 / +1.32%
Today’s Change
39.07
Today|||52-Week Range
65.51
-12.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-39.0M-88.3M-86.6M-17.3M
 
 
 
 
 
Depreciation9.4M10.2M9.0M8.3M
 
 
 
 
 
Total Other Cash Flow30.7M78.6M117.0M139.5M
 
 
 
 
 
Funds From Operations1.1M554.0K39.4M130.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.2M-20.6M151.5M-43.6M
 
 
 
 
 
Net Cash Flow - Operating Activities6.3M21.1M-112.1M174.1M
 
 
 
 
 
 
InvestingIncrease In Investments-391.9M-493.5M-300.9M-880.3M
 
 
 
 
 
Decrease In Investments320.1M445.2M369.0M559.9M
 
 
 
 
 
Capital Expenditures-7.5M-7.7M-11.5M-37.9M
 
 
 
 
 
Net Cash Flow Investing-82.8M-60.1M56.6M-358.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.00----
Long Term Borrowings487.0M8.5M4.0M59.8M
 
 
 
 
 
Long Term Debt Reduction-452.0M-9.1M-7.1M-83.7M
 
 
 
 
 
Net Proceeds Stock Sale23.1M24.9M12.6M253.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.5M396.0K1.9M0.00
 
 
 
 
Other Uses - Financing------0.00--
Net Cash Flow - Financing59.6M24.7M11.4M229.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-17.0M-14.2M-44.1M44.9M